Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4
Public ClinicalTrials.gov record NCT07679581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cannabis and Memory
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Study identification
- NCT ID
- NCT07679581
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2025
- Primary completion
- Jan 31, 2027
- Completion
- May 30, 2027
- Last update posted
- Jun 30, 2026
2025 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Innovation and Creativity (CINC) | Boulder | Colorado | 80301 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cannabis trials
Other public records listing Cannabis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07699198: Developing and Strengthening Cannabis Warnings: Warning Message Testing Not yet recruiting
- NCT05401929: Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users Recruiting
- NCT07603518: The Pharmacokinetics of a Hemp-Based Topical Product Not yet recruiting
- NCT07434895: Repeated CBD Administration and Cannabis Outcomes Recruiting
- NCT05514899: Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV Recruiting
- NCT04704271: Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07679581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2026 · Synced Aug 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07679581 live on ClinicalTrials.gov.